FDA Approves Moderna's mRNA Vaccine for Seasonal Flu, First of Its Kind

The U.S. Food and Drug Administration has approved Moderna's mRNA vaccine for seasonal flu, marking the first of its kind. Clinical trials indicated the vaccine could be up to 27 percent more effective than standard flu shots.